Elissa Hudspeth

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

Wen‐Hsiang Chen, Lanying Du, Shivali Chag et al. · Human Vaccines & Immunotherapeutics · 2013 · 128 citations · Full text

Vaccination, Rbd Vaccine Candidate, Vaccine Development +15

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

Wen‐Hsiang Chen, Shivali Chag, Mohan‐Vivekanandan Poongavanam et al. · Journal of Pharmaceutical Sciences · 2017 · 115 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +7

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates

Nerea Zabaleta, Wenlong Dai, Urja Bhatt et al. · Cell Host & Microbe · 2021 · 79 citations · Full text

Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease

Christopher A. Seid, Kathryn M. Jones, Jeroen Pollet et al. · Human Vaccines & Immunotherapeutics · 2016 · 59 citations · Full text

Cysteine Mutagenesis, Immunodeficiencies, Immunology +22

Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice

Viridiana Martínez-Campos, Pedro Pablo Martínez-Vega, María Jesús Ramírez-Sierra et al. · Vaccine · 2015 · 59 citations

Vaccination, Mucosal Vaccination, Protective Efficacy +11